Start of the RADAR-AD tier 2 study – technologies installed in participants’ homes
The RADAR-AD sub-study (tier 2) is a multicentre, observational digital assessment study among participants with
RADAR-AD
Preliminary results from RADAR-AD presented at AAIC
The RADAR-AD study aims at leveraging different combinations of wearables and smartphone applications in three
Detecting digital markers for Alzheimer’s disease with RADAR-base
The RADAR-AD project (Remote Assessment of Disease and Relapse – Alzheimer’s Disease) is an initiative
Neuronet Working Groups emphasise the importance of effective collaboration to overcome obstacles linked to patient privacy and data sharing
As a coordination and support action, Neuronet has been designed to enhance the impact and
Communication representatives of neurodegeneration research projects exchange on best practices
On 7 May, representatives of 12 Innovative Medicines Initiative neurodegeneration research projects met virtually to
RADAR-AD project members gather online for the second annual consortium meeting to discuss progress and future plans
The annual RADAR-AD meeting provides consortium members from various work streams with the opportunity to
Spotlight on early-career researchers: a Neuronet interview with Colin Birkenbihl
In this Neuronet interview, we speak to Colin Birkenbihl, a doctoral candidate at the Fraunhofer
Neuronet convenes 6th meeting of its Scientific Coordination Board
On 22 March, the Innovative Medicines Initiative (IMI) funded Neuronet Coordination and Support Action convened
Working Group on HTA & regulatory interactions holds meeting, identifying key challenges to the use & development of digital endpoints
On 15 February, Neuronet hosted an online meeting of its Working Group on Health Technology
Research Programme on Neurodegeneration Featured at Alzheimer Europe Conference
In 2019, the Neuronet Sessions introduced the projects of the Innovative Medicines Initiative (IMI) neurodegeneration